Skip to main content

Cell Free Synthesis of Biologics

A Comprehensive Guide

  • 1st Edition - September 1, 2026
  • Latest edition
  • Author: Sarfaraz Niazi
  • Language: English

Cell Free Synthesis of Biologics: A Comprehensive Guide addresses the need for efficient production methods in biopharmaceutical manufacturing. As the demand for biologics contin… Read more

Description

Cell Free Synthesis of Biologics: A Comprehensive Guide addresses the need for efficient production methods in biopharmaceutical manufacturing. As the demand for biologics continues to rise, traditional cell-based production systems often fall short due to high costs and complexity. This book offers a detailed exploration of cell-free protein synthesis (CFPS), providing researchers and professionals with the latest methodologies, best practices, and troubleshooting strategies necessary for successful implementation. The content is structured into comprehensive chapters that cover the historical development, technical foundations, optimization strategies, advanced technologies, and the regulatory landscape surrounding CFPS.

Each section is designed to guide users through the complexities of establishing and scaling up cell-free systems, ensuring a clear understanding of the processes involved and the potential applications in therapeutic development, diagnostics, and industrial biotechnology. This book provides pharmaceutical scientists and pharma manufacturing professionals with practical insights and innovative strategies to enhance efficiency and reduce costs in biopharmaceutical production.

Key features

  • Provides comprehensive protocols for cell-free protein synthesis technologies
  • Insights into regulatory considerations and compliance for biologics
  • Covers strategies for optimizing production and scaling up processes
  • Includes real-world applications in biomanufacturing and diagnostics
  • Develops economic analysis for cost-effective biopharmaceutical production

Readership

Pharmaceutical Scientists, and biological products developers

Table of contents

Part I: Introduction and Historical Development

1. Introduction to Cell-Free Protein Synthesis

2. Historical Evolution of Cell-Free Systems

Part II: Technical Foundations and Optimization Strategies

3. Optimization of Cell Extract Preparation

4. Biochemical Foundations of Cell-Free Systems

5. DNA Template Design and Genetic Optimization

6. Reaction Condition Optimization

7. Extract Preparation Methodologies

Part III: Advanced Technologies and Innovations

8. Engineering the Cell-Free Environment

9. Incorporating Non-Standard Amino Acids

10. Membrane Protein Synthesis

Part IV: Scale-Up, Process Implementation, and Automation

11. Scale-Up Strategies

12. Industrial Scale Process Design

13. Quality Control and Analytical Methods

14. Downstream Processing and Purification

Part V: Applications and Product Development

15. Therapeutic Proteins and Biologics

16. Industrial Enzymes and Catalysts

17. Diagnostic and Research Tools

Part VI: Regulatory, Compliance, and Commercial Landscape

18. Regulatory Considerations

19. Documentation and Compliance

20. Intellectual Property Landscape

21. Economic Analysis and Business Models

Part VII: Future Directions and Emerging Technologies

22. Emerging Technologies in Cell-Free Synthesis

23. New Product Opportunities

24. Collaboration, Data Sharing, and Knowledge Transfer

25. Vision for the Future of Protein Manufacturing

Product details

  • Edition: 1
  • Latest edition
  • Published: September 1, 2026
  • Language: English

About the author

SN

Sarfaraz Niazi

Sarfaraz Niazi, Ph.D., is an adjunct professor at the University of Illinois and the University of Houston. He has authored 60+ major books, 100+ research papers, and 100+ patents, mainly in the fields of bioprocessing, drug discovery, drug formulations, thermodynamic systems, alcohol aging, nutraceuticals, and the treatment of autoimmune diseases. He has hands-on experience in establishing biotechnology projects, from concept to market, including FDA approval. He also serves as an advisor to major pharmaceutical and biopharmaceutical companies, regulatory agencies, and many heads of state, and is a patent law practitioner.
Affiliations and expertise
University of Illinois, Chicago, USA